Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerIntegrative network modeling approaches to personalized cancer medicineStrategies for modern biomarker and drug development in oncology.Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survivalQuantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.Liquid Biopsies for Cancer: Coming to a Patient near You.Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.
P2860
Q26746010-FEEA6A7A-7B0C-4C60-BA7B-068AE724F951Q28602016-226D3572-4D53-403C-86E1-0BEDC2CD03D4Q30590270-D90C3425-1E33-4F9C-BB4D-3057BD636A04Q33641924-5B159FFD-5EB2-4C62-A719-C547E7E83C17Q35881722-FBB1A494-6F56-4BE5-8291-54530EE01B46Q35946342-AD36EB32-C7BA-46A7-B65D-9C4D7187611DQ36104229-5F7AD85E-1862-4261-A768-0E4BA68FDE76Q36546798-69137619-6723-4D50-A139-F6ED07FA1AB7Q37110941-C2DC4EA0-2CE6-43B5-9040-F1A797F5F271Q37628173-E504748C-CCB2-4417-9353-C13822EC70F5Q38616195-41ECBD23-F851-4CE3-BAD4-0881FDCED667Q47094357-942D689B-FF40-4BDD-A829-8575C8D0C983Q53602004-2A5965CB-87B8-40E3-B787-D1B4E69B0C40
P2860
Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@en
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@nl
type
label
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@en
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@nl
prefLabel
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@en
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@nl
P2093
P2860
P356
P1433
P1476
Personalized ovarian cancer di ...... rget in circulating tumor DNA.
@en
P2093
Bojan Losic
Catalina Camacho
Dagny Miller
Elena Pereira
Eric Schadt
Hardik Shah
John A Martignetti
Leopold Garnar-Wortzel
P2860
P304
P356
10.1593/NEO.131900
P577
2014-01-01T00:00:00Z